(Q41457713)

30 September 2017

1 reference

title

Everything you always wanted to know about cellular drug resistance in childhood acute lymphoblastic leukemia (English)

1 reference

30 September 2017

1 reference

Pieters R

1

1 reference

30 September 2017

Klumper E

series ordinal

2

1 reference

30 September 2017

Kaspers GJ

series ordinal

3

1 reference

30 September 2017

Veerman AJ

series ordinal

4

1 reference

30 September 2017

publication date

1 January 1997

1 reference

Critical Reviews in Oncology Hematology

30 September 2017

published in

1 reference

30 September 2017

volume

25

1 reference

30 September 2017

issue

1

1 reference

30 September 2017

page(s)

11-26

1 reference

Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Acute lymphoblastic leukemia in childhood.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

1 reference

7 January 2021

High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Clinical pharmacology of cancer chemotherapy in children.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Drug sensitivity assays in leukaemia and lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Clinical relevance of predictive tests for cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Predictive chemosensitivity testing

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

In vitro assays to predict drug sensitivity and drug resistance. A panel discussion.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Highly specific prediction of antineoplastic drug resistance with an in vitro assay using suprapharmacologic drug exposures.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

An in vitro chemosensitivity test for the screening of anti-cancer drugs in childhood leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Adaptation of the rapid automated tetrazolium dye based (MTT) assay for chemosensitivity testing in childhood leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Comparison of the rapid automated MTT-assay with a dye exclusion assay for chemosensitivity testing in childhood leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

In vitro determination of tumour chemosensitivity in haematological malignancies.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Mononuclear cells contaminating acute lymphoblastic leukaemic samples tested for cellular drug resistance using the methyl-thiazol-tetrazolium assay

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Prediction of remission induction in childhood acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Multivariate analysis of prognostic factors in acute myeloid leukemia: value of clonogenic leukemic cell properties

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Prediction of chemotherapy response in human leukemia using in vitro chemosensitivity test.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

In vitro chemosensitivity testing of leukemic cells: prediction of response to chemotherapy in patients with acute non-lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA)

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Correlations between therapeutic response of leukaemias and in-vitro drug-sensitivity assay

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Pretherapeutic Drug Testing in Acute Leukemias for Prediction of Individual Prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

In vitro drug testing in patients with acute leukemia with incubations mimicking in vivo intracellular drug concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Apoptosis induced by anticancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Glucocorticoid resistance in childhood leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

The use of glucocorticoids in acute lymphoblastic leukemia of childhood. Molecular, cellular, and clinical considerations.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Glucocorticoid receptors and resistance to glucocorticoids in hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

[Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83)]

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

A test with dexamethasone in acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Prediction of clinical response to glucocorticoids in children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

The relationship of blast cell glucocorticoid receptor levels to response to single-agent steroid trial and remission response in children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Sequential studies of lymphoblast glucocorticoid receptor levels at diagnosis and relapse in childhood leukemia: an update.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Different types of non-P-glycoprotein mediated multiple drug resistance in children with relapsed acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Therapeutic and prognostic implications of glucocorticoid receptors and terminal deoxynucleotidyl transferase in acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Impact of treatment efficacy on the prognostic value of glucocorticoid receptor levels in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Glucocorticoid receptor studies in human leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Glucocorticoid receptors predict response to combination chemotherapy in patients with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Response of recurrent acute lymphoblastic leukemia to glucocorticoids: serial studies of receptor content, in vivo cytokinetic changes and clinical responses.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Glucocorticoid receptors in childhood acute non-lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral blood

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Nuclear translocation of lymphoblast glucocorticoid receptors in childhood leukemia does not predict steroid responsiveness.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Comparison of the antileukemic activity in vitro of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Pharmacokinetics of prednisolone in children with acute lymphoblastic leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Asparagine synthetase in normal and malignant tissues; correlation with tumor sensitivity to asparaginase

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Inhibition of malignant human neoplasms with L-asparaginase

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

l-Asparaginase resistance in human leukemia—Asparagine synthetase

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Modulation of antifolate cytotoxicity by metabolites from dying cells in a lymphocyte clonal assay.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Methotrexate cytotoxicity determination using the MTT assay following enzymatic depletion of thymidine and hypoxanthine.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Accumulation of methotrexate polyglutamates in lymphoblasts is a determinant of antileukemic effects in vivo. A rationale for high-dose methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Basis for natural resistance to methotrexate in human acute non-lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Increased dihydrofolate reductase activity in methotrexate-resistant human promyelocytic-leukaemia (HL-60) cells. Lack of correlation between increased activity and overproduction

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Mechanisms of acquired resistance to methotrexate in a human squamous carcinoma cell line of the head and neck, exposed to different treatment schedules

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

The cytotoxicity of thioguanine vs mercaptopurine in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Prognostic value of 5'nucleotidase in acute lymphoblastic leukemia with the common-ALL phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Relation of 5'-nucleotidase and phosphatase activities with immunophenotype, drug resistance and clinical prognosis in childhood leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Non-T, non-B childhood acute lymphoblastic leukemia. Correlation between cytochemical markers and first complete remission

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Prognostic significance of acid alpha-naphthyl acetate esterase and acid phosphatase in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Effects of adenosine and deoxyadenosine on pha-stimulation of lymphocytes of man, horse and pig

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Mechanisms of drug resistance in acute leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Hypoxanthine-guanine phosphoribosyl-transferase in childhood leukemia: relation with immunophenotype, in vitro drug resistance and clinical prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Thiopurine pharmacogenetics in leukemia: correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Intracellular retention of cytosine arabinoside triphosphate in blast cells from children with acute myelogenous and lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Clinical and cell biological features related to cellular drug resistance of childhood acute lymphoblastic leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

In vitro anthracycline cross-resistance pattern in childhood acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Plasma membrane lipid composition of vinblastine sensitive and resistant human leukaemic lymphoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

P-glycoprotein and glutathione S-transferase pi in childhood acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Expression of mdr1, mrp, topoisomerase II alpha/beta, and cyclin A in primary or relapsed states of acute lymphoblastic leukaemias.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Failure to detect the P-glycoprotein multidrug resistant phenotype in cases of resistant childhood acute lymphocytic leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Detection of multidrug-resistant protein, P-glycoprotein in childhood leukaemia and lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Reactivity of P-glycoprotein monoclonal antibodies in childhood cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Comparative uptake, retention and action of vincristine, vinblastine and vindesine on murine leukaemic lymphoblasts sensitive and resistant to vincristine

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Messenger RNA expression of resistance factors and their correlation to the proliferative activity in childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Sensitivity of primary clonogenic blasts from acute lymphoblastic leukemia patients to an activated cyclophosphamide, viz., mafosfamide.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

Purification and characterization of a pi class glutathione S-transferase from human leukaemic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2896%2900223-5

7 January 2021

10.1016/S1040-8428(96)00223-5

Identifiers

DOI

1 reference

30 September 2017

1 reference